XENETIC BIOSCIENCES INC
XBIO · NASDAQ
Updated at 2026-10-15 08:35:28
- Today's High
- $2.14
- Today’s Low
- $2.07
%22%2F%3E%0A%3Cpath%20id%3D%22%26%23230%3B%26%23150%3B%26%23135%3B%26%23230%3B%26%23161%3B%26%23163%3B%26%23230%3B%26%23154%3B%26%23151%3B%26%23232%3B%26%23167%3B%26%23146%3B%22%20d%3D%22M48.3363%2013.4132H60.2082L46.795%205.72205e-06V11.8719C46.795%2012.7231%2047.4851%2013.4132%2048.3363%2013.4132Z%22%20fill%3D%22var(--fill-0%2C%20%23474741)%22%2F%3E%0A%3Cpath%20id%3D%22%26%23230%3B%26%23148%3B%26%23190%3B%26%23229%3B%26%23164%3B%26%23167%3B%26%23233%3B%26%23149%3B%26%23156%3B%22%20fill-rule%3D%22evenodd%22%20clip-rule%3D%22evenodd%22%20d%3D%22M11.3812%2020.3725C16.7977%2014.9559%2025.5803%2014.9559%2030.9969%2020.3725C36.413%2025.789%2036.4131%2034.5707%2030.9969%2039.9872C26.0109%2044.973%2018.1729%2045.3699%2012.7335%2041.1769L2.54298%2051.3684L0%2048.8254L10.1915%2038.6329C5.99993%2033.1937%206.39609%2025.3579%2011.3812%2020.3725ZM28.4539%2022.9155C24.4418%2018.9033%2017.9363%2018.9033%2013.9241%2022.9155C9.91245%2026.9275%209.91241%2033.4322%2013.9241%2037.4442C17.9362%2041.4562%2024.4418%2041.4562%2028.4539%2037.4442C32.4656%2033.4322%2032.4656%2026.9275%2028.4539%2022.9155Z%22%20fill%3D%22var(--fill-0%2C%20%235D5D56)%22%2F%3E%0A%3C%2Fg%3E%0A%20%20%3C%2Fsvg%3E%0A%3C%2Fsvg%3E%0A)
Candlestick trends are for reference. Refer to the trading page for actual data.
Key Statistics
- Previous Open
- $2.07
- Previous Close
- $2.10
- Volume
- 12.57K
- Market Cap
- $5.84M
- P/E Ratio
- --
- EPS
- $-1.20
Previous Day Range
52-Week Range
Company Overview
- Sector
- HEALTHCARE
- Industry
- Biotechnology
- Sub-industry
- BIOTECHNOLOGY
- Headquarters
- 945 CONCORD STREET, FRAMINGHAM, MA, UNITED STATES, 01701
- Country
- US
- Listing Date
- 2016-11-07
- Fiscal Year End
- December
- Shares Outstanding
- 2.29M
- CIK
- 0001534525
- Website
- www.xeneticbio.com
Xenetic Biosciences, Inc., a biopharmaceutical company, is focused on advancing XCART, a customized chimeric antigen receptor T (CAR T) platform technology designed to target patient-specific tumor neoantigens. The company is headquartered in Framingham, Massachusetts.
Financial Metrics
Revenue
2026-06-30
$660.6K
2026-03-31
$806.92K
2025-12-31
$766.29K
2025-09-30
$1.02M
Operating Expenses
2026-06-30
$1.63M
2026-03-31
$1.3M
2025-12-31
$1.38M
2025-09-30
$1.57M
Net Income
2026-06-30
-$929.69K
2026-03-31
-$456.38K
2025-12-31
-$579.07K
2025-09-30
-$509.93K
Net Profit Margin
2026-06-30
-140.73%
2026-03-31
-56.55%
2025-12-31
-75.56%
2025-09-30
-49.65%
Earnings Per Share
2026-06-30
$-0.41
2026-03-31
$-0.19
2025-12-31
$-0.22
2025-09-30
$-0.33
Earnings Before Interest, Taxes, Depreciation, and Amortization
2026-06-30
-$929.69K
2026-03-31
-$456.38K
2025-12-31
-$579.07K
2025-09-30
-$509.93K
Effective Tax Rate
2026-06-30
--
2026-03-31
--
2025-12-31
--
2025-09-30
--
| Item | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 |
|---|---|---|---|---|
| Revenue | $660.6K | $806.92K | $766.29K | $1.02M |
| Operating Expenses | $1.63M | $1.3M | $1.38M | $1.57M |
| Net Income | -$929.69K | -$456.38K | -$579.07K | -$509.93K |
| Net Profit Margin | -140.73% | -56.55% | -75.56% | -49.65% |
| Earnings Per Share | $-0.41 | $-0.19 | $-0.22 | $-0.33 |
| Earnings Before Interest, Taxes, Depreciation, and Amortization | -$929.69K | -$456.38K | -$579.07K | -$509.93K |
| Effective Tax Rate | -- | -- | -- | -- |
FAQs
Risk Warning
Stock prices can be highly volatile and may rise or fall sharply in a short period. Digital asset and derivative products involve additional risks such as leverage and liquidity. Content on this page is for reference only and does not constitute investment advice. Product availability and access may vary by region and applicable regulations.